Inventor · disambiguated record
Valerie Odegard
Also filed as: ODEGARD VALERIE
4 granted patents·12 pending applications·7 citations·filing 2009–2021
63Inventor score
Files withSILVERBACK THERAPEUTICS INC9EMERGENT PRODUCT DEV SEATTLE3JUNO THERAPEUTICS INC3ARARIS BIOTECH AG1
Top patents by PatentIndex Score
16 records- 0194US11179473B2Nectin-4 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Nov 23, 2021·7 cites·30 claims
- 0265US12364768B2Nectin-4 antibody conjugates and uses thereofARARIS BIOTECH AG·Filed 2021·Granted Jul 22, 2025·0 cites·21 claims
- 0365US11541126B1Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·30 claims
- 0463US2023062712A1Anti-asgr1 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0559US2011217302A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2009·Application pending·0 cites
- 0650US2013189261A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
- 0750US2020113912A1Methods and Compositions for the Treatment of Disease with Immune Stimulatory ConjugatesSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0850US2021130473A1TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0950US2021154317A1Compositions and methods for the treatment of viral infectionsSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1049US2022249685A1Anti-mesothelin antibodies and immunoconjugates thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1149US2021115109A1Conjugates and methods of use thereof for selective delivery of immune-modulatory agentsSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1244US2017008960A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2016·Application pending·0 cites
- 1343US2020199247A1Antibody conjugates of immune-modulatory compounds and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1439US12163952B2Determining toxicity risk in CAR T-cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·0 cites·28 claims
- 1534US2018161368A1Composition and methods for regulating inhibitory interactions in genetically engineered cellsJUNO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1632US2018319862A1Chimeric receptors containing traf-inducing domains and related compositions and methodsJUNO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valerie Odegard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →